nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—FCGR1A—FCGR activation—FCGR2A—malaria	0.0792	0.221	CbGpPWpGaD
Methyl aminolevulinate—Phototoxicity—Dapsone—malaria	0.0481	0.0748	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—FCGR2A—malaria	0.0469	0.131	CbGpPWpGaD
Methyl aminolevulinate—Pain of skin—Clindamycin—malaria	0.0378	0.0589	CcSEcCtD
Methyl aminolevulinate—Localized exfoliation—Dapsone—malaria	0.0342	0.0533	CcSEcCtD
Methyl aminolevulinate—Localized exfoliation—Clindamycin—malaria	0.0331	0.0515	CcSEcCtD
Methyl aminolevulinate—Allergic contact dermatitis—Quinidine—malaria	0.025	0.039	CcSEcCtD
Methyl aminolevulinate—Allergic contact dermatitis—Quinine—malaria	0.025	0.039	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—FCGR2A—malaria	0.0243	0.0679	CbGpPWpGaD
Methyl aminolevulinate—Allergic contact dermatitis—Quinidine barbiturate—malaria	0.0226	0.0352	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—FCGR2A—malaria	0.0183	0.0512	CbGpPWpGaD
Methyl aminolevulinate—Burning sensation—Sulfadiazine—malaria	0.0172	0.0268	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—CISH—malaria	0.0128	0.0357	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—HLA-B—malaria	0.0122	0.0342	CbGpPWpGaD
Methyl aminolevulinate—Skin exfoliation—Sulfadiazine—malaria	0.0114	0.0178	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Clindamycin—malaria	0.0112	0.0174	CcSEcCtD
Methyl aminolevulinate—Stinging—Clindamycin—malaria	0.011	0.0171	CcSEcCtD
Methyl aminolevulinate—Blister—Quinidine barbiturate—malaria	0.011	0.017	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—HLA-B—malaria	0.0109	0.0304	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—CD36—malaria	0.0107	0.0298	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—ICAM1—malaria	0.00994	0.0278	CbGpPWpGaD
Methyl aminolevulinate—Ulcer—Clindamycin—malaria	0.00943	0.0147	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Clindamycin—malaria	0.00881	0.0137	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Dapsone—malaria	0.0088	0.0137	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Quinidine—malaria	0.00864	0.0135	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Quinine—malaria	0.00864	0.0135	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Clindamycin—malaria	0.00851	0.0132	CcSEcCtD
Methyl aminolevulinate—Erythema—Proguanil—malaria	0.00788	0.0123	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Quinidine barbiturate—malaria	0.0078	0.0121	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IFNG—malaria	0.00757	0.0212	CbGpPWpGaD
Methyl aminolevulinate—Swelling—Clindamycin—malaria	0.00734	0.0114	CcSEcCtD
Methyl aminolevulinate—Eczema—Quinidine—malaria	0.00706	0.011	CcSEcCtD
Methyl aminolevulinate—Eczema—Quinine—malaria	0.00706	0.011	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Clindamycin—malaria	0.00677	0.0105	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Quinidine—malaria	0.00664	0.0103	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Quinine—malaria	0.00664	0.0103	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FCGR2B—malaria	0.00649	0.0182	CbGpPWpGaD
Methyl aminolevulinate—Swelling—Pentoxifylline—malaria	0.00648	0.0101	CcSEcCtD
Methyl aminolevulinate—Eczema—Quinidine barbiturate—malaria	0.00638	0.00992	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Pyrimethamine—malaria	0.00609	0.00947	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TIRAP—malaria	0.00603	0.0169	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis bullous—Quinidine barbiturate—malaria	0.00599	0.00933	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—HLA-B—malaria	0.00598	0.0167	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CR1—malaria	0.0056	0.0157	CbGpPWpGaD
Methyl aminolevulinate—Photosensitivity reaction—Dapsone—malaria	0.00528	0.00822	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Clindamycin—malaria	0.00511	0.00795	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Quinidine—malaria	0.00501	0.0078	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Quinine—malaria	0.00501	0.0078	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—ICAM1—malaria	0.00486	0.0136	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TLR9—malaria	0.00476	0.0133	CbGpPWpGaD
Methyl aminolevulinate—Photosensitivity reaction—Quinidine barbiturate—malaria	0.00452	0.00704	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—HLA-B—malaria	0.00434	0.0121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CD36—malaria	0.00426	0.0119	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL18—malaria	0.00421	0.0118	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CISH—malaria	0.00417	0.0117	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Quinine—malaria	0.0041	0.00639	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Quinidine—malaria	0.0041	0.00639	CcSEcCtD
Methyl aminolevulinate—Rash—Proguanil—malaria	0.00406	0.00632	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Proguanil—malaria	0.00405	0.00631	CcSEcCtD
Methyl aminolevulinate—Headache—Proguanil—malaria	0.00403	0.00627	CcSEcCtD
Methyl aminolevulinate—Erythema—Dapsone—malaria	0.00403	0.00627	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-B—malaria	0.00399	0.0112	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FCGR2B—malaria	0.00394	0.011	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Clindamycin—malaria	0.0039	0.00607	CcSEcCtD
Methyl aminolevulinate—Erythema—Quinine—malaria	0.00382	0.00595	CcSEcCtD
Methyl aminolevulinate—Erythema—Quinidine—malaria	0.00382	0.00595	CcSEcCtD
Methyl aminolevulinate—Nausea—Proguanil—malaria	0.00382	0.00595	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FCGR2A—malaria	0.00381	0.0107	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Quinidine barbiturate—malaria	0.0037	0.00577	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNG—malaria	0.00369	0.0103	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TIRAP—malaria	0.00351	0.00982	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Quinidine barbiturate—malaria	0.00345	0.00537	CcSEcCtD
Methyl aminolevulinate—Erythema—Pentoxifylline—malaria	0.00344	0.00536	CcSEcCtD
Methyl aminolevulinate—Urticaria—Sulfadiazine—malaria	0.00339	0.00528	CcSEcCtD
Methyl aminolevulinate—Discomfort—Clindamycin—malaria	0.00328	0.0051	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CR1—malaria	0.00326	0.00913	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—ICAM1—malaria	0.00324	0.00907	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Sulfadiazine—malaria	0.00315	0.0049	CcSEcCtD
Methyl aminolevulinate—Oedema—Quinidine—malaria	0.00312	0.00486	CcSEcCtD
Methyl aminolevulinate—Oedema—Quinine—malaria	0.00312	0.00486	CcSEcCtD
Methyl aminolevulinate—Pruritus—Sulfadiazine—malaria	0.00302	0.0047	CcSEcCtD
Methyl aminolevulinate—Discomfort—Pentoxifylline—malaria	0.0029	0.00451	CcSEcCtD
Methyl aminolevulinate—Oedema—Quinidine barbiturate—malaria	0.00282	0.00438	CcSEcCtD
Methyl aminolevulinate—Oedema—Pentoxifylline—malaria	0.00281	0.00438	CcSEcCtD
Methyl aminolevulinate—Infection—Pentoxifylline—malaria	0.00279	0.00435	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—TLR9—malaria	0.00277	0.00776	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Clindamycin—malaria	0.00274	0.00427	CcSEcCtD
Methyl aminolevulinate—Pain—Clindamycin—malaria	0.00272	0.00423	CcSEcCtD
Methyl aminolevulinate—Rash—Sulfadiazine—malaria	0.00269	0.00419	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Sulfadiazine—malaria	0.00269	0.00419	CcSEcCtD
Methyl aminolevulinate—Headache—Sulfadiazine—malaria	0.00268	0.00416	CcSEcCtD
Methyl aminolevulinate—Nausea—Sulfadiazine—malaria	0.00254	0.00395	CcSEcCtD
Methyl aminolevulinate—Urticaria—Clindamycin—malaria	0.00253	0.00393	CcSEcCtD
Methyl aminolevulinate—Urticaria—Quinine—malaria	0.00248	0.00386	CcSEcCtD
Methyl aminolevulinate—Urticaria—Quinidine—malaria	0.00248	0.00386	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNG—malaria	0.00247	0.0069	CbGpPWpGaD
Methyl aminolevulinate—Pain—Quinidine barbiturate—malaria	0.00241	0.00375	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Clindamycin—malaria	0.00234	0.00365	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Quinidine—malaria	0.0023	0.00358	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Quinine—malaria	0.0023	0.00358	CcSEcCtD
Methyl aminolevulinate—Asthenia—Clindamycin—malaria	0.00228	0.00355	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD40LG—malaria	0.00226	0.00632	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Clindamycin—malaria	0.00225	0.0035	CcSEcCtD
Methyl aminolevulinate—Asthenia—Quinidine—malaria	0.00224	0.00348	CcSEcCtD
Methyl aminolevulinate—Asthenia—Quinine—malaria	0.00224	0.00348	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HLA-B—malaria	0.00224	0.00626	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Quinidine barbiturate—malaria	0.00224	0.00348	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD8A—malaria	0.00223	0.00625	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Pentoxifylline—malaria	0.00223	0.00348	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FCGR2A—malaria	0.00222	0.0062	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Quinidine—malaria	0.00221	0.00344	CcSEcCtD
Methyl aminolevulinate—Pruritus—Quinine—malaria	0.00221	0.00344	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1B—malaria	0.0022	0.00615	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD36—malaria	0.00219	0.00614	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL2—malaria	0.00219	0.00613	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-B—malaria	0.00215	0.00601	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD36—malaria	0.00211	0.00589	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Clindamycin—malaria	0.0021	0.00327	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Quinidine barbiturate—malaria	0.00207	0.00323	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Pentoxifylline—malaria	0.00207	0.00322	CcSEcCtD
Methyl aminolevulinate—Dizziness—Quinine—malaria	0.00206	0.00321	CcSEcCtD
Methyl aminolevulinate—Dizziness—Quinidine—malaria	0.00206	0.00321	CcSEcCtD
Methyl aminolevulinate—Headache—Dapsone—malaria	0.00206	0.00321	CcSEcCtD
Methyl aminolevulinate—Asthenia—Quinidine barbiturate—malaria	0.00202	0.00314	CcSEcCtD
Methyl aminolevulinate—Asthenia—Pentoxifylline—malaria	0.00202	0.00314	CcSEcCtD
Methyl aminolevulinate—Rash—Clindamycin—malaria	0.00201	0.00312	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Clindamycin—malaria	0.002	0.00312	CcSEcCtD
Methyl aminolevulinate—Headache—Clindamycin—malaria	0.00199	0.0031	CcSEcCtD
Methyl aminolevulinate—Pruritus—Quinidine barbiturate—malaria	0.00199	0.0031	CcSEcCtD
Methyl aminolevulinate—Pruritus—Pentoxifylline—malaria	0.00199	0.0031	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CRP—malaria	0.00198	0.00553	CbGpPWpGaD
Methyl aminolevulinate—Rash—Quinine—malaria	0.00197	0.00306	CcSEcCtD
Methyl aminolevulinate—Rash—Quinidine—malaria	0.00197	0.00306	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Quinidine—malaria	0.00197	0.00306	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Quinine—malaria	0.00197	0.00306	CcSEcCtD
Methyl aminolevulinate—Headache—Quinine—malaria	0.00195	0.00304	CcSEcCtD
Methyl aminolevulinate—Headache—Quinidine—malaria	0.00195	0.00304	CcSEcCtD
Methyl aminolevulinate—Nausea—Dapsone—malaria	0.00195	0.00304	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TLR4—malaria	0.0019	0.0053	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Clindamycin—malaria	0.00189	0.00294	CcSEcCtD
Methyl aminolevulinate—Dizziness—Quinidine barbiturate—malaria	0.00186	0.0029	CcSEcCtD
Methyl aminolevulinate—Dizziness—Pentoxifylline—malaria	0.00186	0.00289	CcSEcCtD
Methyl aminolevulinate—Nausea—Quinidine—malaria	0.00185	0.00288	CcSEcCtD
Methyl aminolevulinate—Nausea—Quinine—malaria	0.00185	0.00288	CcSEcCtD
Methyl aminolevulinate—Rash—Quinidine barbiturate—malaria	0.00178	0.00276	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Quinidine barbiturate—malaria	0.00177	0.00276	CcSEcCtD
Methyl aminolevulinate—Rash—Pentoxifylline—malaria	0.00177	0.00276	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Pentoxifylline—malaria	0.00177	0.00276	CcSEcCtD
Methyl aminolevulinate—Headache—Quinidine barbiturate—malaria	0.00176	0.00275	CcSEcCtD
Methyl aminolevulinate—Headache—Pentoxifylline—malaria	0.00176	0.00274	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ICAM1—malaria	0.00175	0.00488	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Quinidine barbiturate—malaria	0.00167	0.0026	CcSEcCtD
Methyl aminolevulinate—Nausea—Pentoxifylline—malaria	0.00167	0.0026	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IL18—malaria	0.00138	0.00385	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD40LG—malaria	0.00137	0.00383	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD8A—malaria	0.00135	0.00379	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD4—malaria	0.00134	0.00374	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-B—malaria	0.0013	0.00365	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6—malaria	0.00129	0.0036	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD4—malaria	0.00128	0.00359	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD36—malaria	0.00128	0.00357	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CRP—malaria	0.00115	0.00322	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TLR4—malaria	0.0011	0.00309	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ICAM1—malaria	0.00106	0.00296	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IFNG—malaria	0.000806	0.00225	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD4—malaria	0.000778	0.00218	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6—malaria	0.000723	0.00202	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1B—malaria	0.000719	0.00201	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL2—malaria	0.000716	0.002	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6—malaria	0.000421	0.00118	CbGpPWpGaD
